Landscape of somatic retrotransposition in human cancers
- PMID: 22745252
- PMCID: PMC3656569
- DOI: 10.1126/science.1222077
Landscape of somatic retrotransposition in human cancers
Abstract
Transposable elements (TEs) are abundant in the human genome, and some are capable of generating new insertions through RNA intermediates. In cancer, the disruption of cellular mechanisms that normally suppress TE activity may facilitate mutagenic retrotranspositions. We performed single-nucleotide resolution analysis of TE insertions in 43 high-coverage whole-genome sequencing data sets from five cancer types. We identified 194 high-confidence somatic TE insertions, as well as thousands of polymorphic TE insertions in matched normal genomes. Somatic insertions were present in epithelial tumors but not in blood or brain cancers. Somatic L1 insertions tend to occur in genes that are commonly mutated in cancer, disrupt the expression of the target genes, and are biased toward regions of cancer-specific DNA hypomethylation, highlighting their potential impact in tumorigenesis.
Figures
References
Publication types
MeSH terms
Substances
Grants and funding
- K25 AG037596/AG/NIA NIH HHS/United States
- R01GM082798/GM/NIGMS NIH HHS/United States
- R01 GM082798/GM/NIGMS NIH HHS/United States
- U24CA144025/CA/NCI NIH HHS/United States
- U54 HG003273/HG/NHGRI NIH HHS/United States
- RC1HG005482/HG/NHGRI NIH HHS/United States
- U01HG005725/HG/NHGRI NIH HHS/United States
- K25AG037596/AG/NIA NIH HHS/United States
- U01 HG005209/HG/NHGRI NIH HHS/United States
- F32AG039979/AG/NIA NIH HHS/United States
- F32 AG039979/AG/NIA NIH HHS/United States
- T32 CA009172/CA/NCI NIH HHS/United States
- U24 CA144025/CA/NCI NIH HHS/United States
- RC1 HG005482/HG/NHGRI NIH HHS/United States
- U01HG005209/HG/NHGRI NIH HHS/United States
- U01 HG005725/HG/NHGRI NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
